References
- Jones PM, Turkstra TP. Mitigation of rocuronium-induced anaphylaxis by sugammadex: the great unknown. Anaesthesia 2010; 65(1):89–90.
- Abbas SQ. “Desensitization” of opioids: a case study. J Palliat Med 2009; 12(11):987.
- Editorial. Aspirin-induced asthma. Br J Anaesth 1993; 71(5):619–620.
- Park J, Lee J, Park S, Kim D, Jang A, Park C. Serum tryptase levels in aspirin-excerated respiratory disease (AERD). J Allergy Clin Immunol 2009; 123(2), Suppl 1:8.
- Faich GA. Adverse drug-reaction monitoring. N Engl J Med 1986; 65:448–455.
- Szczeklik A. The cyclooxygenase theory of aspirin-induced asthma. Eur Respir J 1990; 3:588–593.
- Settipance GA. Aspirin sensitivity and allergy. Biomed Pharmacother 1988; 42:493–498.
- Widal MF, Abram P, Lermoyez J. Anaphylaxie et idiosyncraise. Presse Med 1922; 22:191–194.
- Prickman LE, Buchstein HF. Hypersensitivity to acetylsalicylic acid (aspirin). J Am Med Assoc 1937; 108:445–449.
- Friedlander S, Feinberg SM. Aspirin allergy: its relationship to chronic intractable asthma. Ann Intern Med 1947; 26:734–739.
- Rachel UL, Donald DS. Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res 2011; 3(1):3–10.
- Soler M, Imhof E, Perruchoud AP. Severe acute asthma. Pathophysiology, clinical assessment, and treatment. Respiration 1990; 57:114–21.
- Szczeklik A, Nizankowska E, Bochenek G, Nagraba K, Mejza F, Swierczynska M. Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy 2001; 31:219–225.
- Marquette CH, Saulnier F, Leroy O, Wallaert B, Chopin C, Demarcq JM, Durocher A, Tonnel AB. Long-term prognosis of near-fatal asthma: a 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis 1992; 146(1):76–81.